Tirzepatide for Weight Loss
Vital IV Infusions Offers Tirzepatide for Weight Loss Treatment in Chatham, NJ
What is Tirzepatide and how does it help with Weight Loss?
How does Tirzepatide work?
Tirzepatide has a unique function that helps individuals feel fuller for longer periods of time, which ultimately leads to a decrease in calorie intake. This is achieved by delaying gastric emptying through the reduction of glucagon secretion in response to glucose levels. By slowing down the process of gastric emptying, Tirzepatide effectively curbs appetite, enhances eating control, and diminishes food cravings.
At Vital IV Infusions, we offer a variety of options for weight loss treatment in Chatham, NJ.
Are you a candidate for Tirzepatide?
There are two qualifications for Tirzepatide:
- A BMI over 30 and no weight-related complications
- A BMI over 27 with weight-related complications
Why is the weight loss goal 10%? What if I want to lose more weight?
What will my food goals be?
Is the medication safe?
Can I take additional weight loss medication, in addition to GLP-1/ GIP incretins?
Does Tirzepatide have side effects?
- Getting the Inside Dope on Ketamine’s Mysterious Ability to Rapidly Relieve Depression – Scientific American (March 2018)
- Intravenous Ketamine for Adolescents with Treatment-Resistant Depression: An Open-Label Study – Journal of Child and Adolescent Psychopharmacology (July 2018)
- Ketamine for Rapid Reduction of Suicidal Thoughts in Major Depression – American Journal of Psychiatry (Dec 2017)
- World-First Ketamine Trial Shows Promise For Geriatric Depression – American Journal of Geriatric Psychiatry (July 2017)
- FDA Data Support Ketamine as Depression Therapy – MedPage Today (May 2017)
- How Ketamine Infusion Will Transform the Way Depression is Treated – The Doctor Weighs In (July 2017)
- Club Drug Ketamine Gains Traction As A Treatment For Depression – NPR.org (Sept 2015)
- Ketamine may be quick, effective treatment for untreatable depression – CBS News (May 2013)
- The Role of Ketamine in Treatment-Resistant Depression: A Systematic Review – National Center for Biotechnology Information (Sept 2014)